Trial · NCT02075008
Adverse events22
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 22
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Injection site reaction | General disorders | QGE031 Every 4 Weeks (q4w) | 45 | 270 | |
| other | Bronchitis | Infections and infestations | QGE031 Every 4 Weeks (q4w) | 20 | 270 | |
| other | Nasopharyngitis | Infections and infestations | QGE031 Every 4 Weeks (q4w) | 33 | 270 | |
| other | Upper respiratory tract infection | Infections and infestations | QGE031 Every 4 Weeks (q4w) | 17 | 270 | |
| other | Asthma | Respiratory, thoracic and mediastinal disorders | QGE031 Every 4 Weeks (q4w) | 80 | 270 | |
| serious | Myocardial infarction | Cardiac disorders | QGE031 Every 4 Weeks (q4w) | 1 | 270 | |
| serious | Vertigo | Ear and labyrinth disorders | QGE031 Every 4 Weeks (q4w) | 1 | 270 | |
| serious | Goitre | Endocrine disorders | QGE031 Every 4 Weeks (q4w) | 1 | 270 | |
| serious | Cholecystitis acute | Hepatobiliary disorders | QGE031 Every 4 Weeks (q4w) | 1 | 270 | |
| serious | Anaphylactic reaction | Immune system disorders | QGE031 Every 4 Weeks (q4w) | 1 | 270 | |
| serious | Drug hypersensitivity | Immune system disorders | QGE031 Every 4 Weeks (q4w) | 1 | 270 | |
| serious | Diverticulitis | Infections and infestations | QGE031 Every 4 Weeks (q4w) | 1 | 270 | |
| serious | Arthritis | Musculoskeletal and connective tissue disorders | QGE031 Every 4 Weeks (q4w) | 1 | 270 | |
| serious | Osteonecrosis | Musculoskeletal and connective tissue disorders | QGE031 Every 4 Weeks (q4w) | 1 | 270 | |
| serious | Benign breast neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | QGE031 Every 4 Weeks (q4w) | 1 | 270 | |
| serious | Renal neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | QGE031 Every 4 Weeks (q4w) | 1 | 270 | |
| serious | Cerebral haemorrhage | Nervous system disorders | QGE031 Every 4 Weeks (q4w) | 1 | 270 | |
| serious | Cerebrovascular accident | Nervous system disorders | QGE031 Every 4 Weeks (q4w) | 2 | 270 | |
| serious | Vertebral artery thrombosis | Nervous system disorders | QGE031 Every 4 Weeks (q4w) | 1 | 270 | |
| serious | Asthma | Respiratory, thoracic and mediastinal disorders | QGE031 Every 4 Weeks (q4w) | 5 | 270 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02075008/events